These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 27748920
1. microRNA-520a-3p inhibits proliferation and cancer stem cell phenotype by targeting HOXD8 in non-small cell lung cancer. Liu Y, Miao L, Ni R, Zhang H, Li L, Wang X, Li X, Wang J. Oncol Rep; 2016 Dec; 36(6):3529-3535. PubMed ID: 27748920 [Abstract] [Full Text] [Related]
2. Long noncoding RNA HOXA-AS2 promotes non-small cell lung cancer progression by regulating miR-520a-3p. Liu Y, Lin X, Zhou S, Zhang P, Shao G, Yang Z. Biosci Rep; 2019 May 31; 39(5):. PubMed ID: 31064819 [Abstract] [Full Text] [Related]
3. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p. Yu L, Chen D, Song J. Thorac Cancer; 2020 Mar 31; 11(3):603-611. PubMed ID: 31953899 [Abstract] [Full Text] [Related]
4. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway. Lv X, Li CY, Han P, Xu XY. Eur Rev Med Pharmacol Sci; 2018 Apr 31; 22(8):2321-2327. PubMed ID: 29762835 [Abstract] [Full Text] [Related]
5. The microRNA-520a-3p inhibits invasion and metastasis by targeting NF-kappaB signaling pathway in non-small cell lung cancer. Fang X, Shi H, Sun F. Clin Transl Oncol; 2022 Aug 31; 24(8):1569-1579. PubMed ID: 35247196 [Abstract] [Full Text] [Related]
6. LncRNA SBF2-AS1 Facilitates Nonsmall Cell Lung Cancer Progression by Targeting miR-520a-3p. Wang Y, Zou Y, Zhang Q, Chen D, Lin L. J Healthc Eng; 2022 Aug 31; 2022():2223149. PubMed ID: 35444785 [Abstract] [Full Text] [Related]
7. Reduced miR-363-3p expression in non-small cell lung cancer is associated with gemcitabine resistance via targeting of CUL4A. Bian WG, Zhou XN, Song S, Chen HT, Shen Y, Chen P. Eur Rev Med Pharmacol Sci; 2019 Jan 31; 23(2):649-659. PubMed ID: 30720173 [Abstract] [Full Text] [Related]
9. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer. Lu YJ, Liu RY, Hu K, Wang Y. Tumour Biol; 2016 Sep 31; 37(9):12685-12695. PubMed ID: 27448300 [Abstract] [Full Text] [Related]
13. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway. Tian W, Yang X, Yang H, Lv M, Sun X, Zhou B. Cell Death Dis; 2021 Oct 30; 12(11):1030. PubMed ID: 34718336 [Abstract] [Full Text] [Related]
14. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma. Xiao P, Liu WL. Int J Clin Exp Pathol; 2015 Oct 30; 8(9):10800-7. PubMed ID: 26617792 [Abstract] [Full Text] [Related]
15. MicroRNA-7 inhibits the malignant phenotypes of non‑small cell lung cancer in vitro by targeting Pax6. Luo J, Li H, Zhang C. Mol Med Rep; 2015 Oct 30; 12(4):5443-8. PubMed ID: 26135959 [Abstract] [Full Text] [Related]
17. Overexpression of MicroRNA-27b Inhibits Proliferation, Migration, and Invasion via Suppression of MET Expression. Zhou H, Liu Y, Xiao L, Hu Z, Xia K. Oncol Res; 2017 Jan 02; 25(1):147-154. PubMed ID: 28081743 [Abstract] [Full Text] [Related]
19. MicroRNA-520a-3p suppresses non-small-cell lung carcinoma by inhibition of High Mobility Group Box 1 (HMGB1). Lv X, Yao L, Nie YQ, Xu XY. Eur Rev Med Pharmacol Sci; 2018 Mar 02; 22(6):1700-1708. PubMed ID: 29630115 [Abstract] [Full Text] [Related]
20. The regulation of Neuropilin 1 expression by miR-338-3p promotes non-small cell lung cancer via changes in EGFR signaling. Ding Z, Zhu J, Zeng Y, Du W, Zhang Y, Tang H, Zheng Y, Qin H, Liu Z, Huang JA. Mol Carcinog; 2019 Jun 02; 58(6):1019-1032. PubMed ID: 30811684 [Abstract] [Full Text] [Related] Page: [Next] [New Search]